Literature DB >> 11888255

Idiopathic familial temporal lobe epilepsy with febrile convulsions.

N Ward1, J Evanson, O C Cockerell.   

Abstract

Efforts to duplicate the genetic and molecular breakthroughs of autosomal dominant frontal lobe epilepsy have lead to increased interest in familial temporal lobe epilepsy. In this report we describe three kindreds. The epilepsy syndrome described manifests after the teenage years and was generally mild and treatment responsive. The predominant seizure types were simple and complex partial seizures, typical of mesial temporal onset. Some family members had febrile convulsions only and others had epilepsy without preceding febrile convulsions. Three patients had both febrile convulsions and temporal lobe epilepsy. High-resolution quantitative and qualitative MRI was normal. The syndrome in these three kindreds is distinct from temporal lobe epilepsy due to mesial temporal sclerosis and febrile convulsions and is probably a form of idiopathic localization related epilepsy. Its relation to other familial temporal lobe epilepsy phenotypes is discussed. Copyright 2002 BEA Trading Ltd.

Entities:  

Mesh:

Year:  2002        PMID: 11888255     DOI: 10.1053/seiz.2001.0570

Source DB:  PubMed          Journal:  Seizure        ISSN: 1059-1311            Impact factor:   3.184


  2 in total

1.  Enteroviruses in chronic fatigue syndrome: "now you see them, now you don't".

Authors:  M C Dalakas
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-10       Impact factor: 10.154

2.  Familial mesial temporal lobe epilepsy (FMTLE) : a clinical and genetic study of 15 Italian families.

Authors:  Pasquale Striano; Antonio Gambardella; Antonietta Coppola; Carlo Di Bonaventura; Giorgia Bovo; Erica Diani; Francesca Boaretto; Gabriella Egeo; Clotilde Ciampa; Angelo Labate; Stefania Testoni; Daniela Passarelli; Ida Manna; Caterina Sferro; Umberto Aguglia; Ferdinando Caranci; Anna Teresa Giallonardo; Salvatore Striano; Carlo Nobile; Roberto Michelucci
Journal:  J Neurol       Date:  2007-11-21       Impact factor: 4.849

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.